Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04218357 · ClinicalTrials.gov registry record · Phase 1
Probenecid as Medication for Alcohol Use Disorder (PROB)
A Phase 1 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT04218357 is a Phase 1 study that has completed, run by Brown University. The registered enrollment target is 35 participants.
The verdict
NCT04218357, a Phase 1 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
The design is a randomized, within-subject, crossover, double-blind, placebo-controlled human alcohol laboratory study with one oral dose of 2g probenecid or placebo administered in two laboratory sessions.
Interventions
- DRUG Probenecid or placebo single administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-12-02 |
| Est. Completion | 2023-05-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04218357
The ClinicalTrials.gov registry entry for NCT04218357 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Probenecid or placebo single administration is the first listed.
NCT04218357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04218357 about?
NCT04218357 is a clinical study titled "Probenecid as Medication for Alcohol Use Disorder (PROB)". The design is a randomized, within-subject, crossover, double-blind, placebo-controlled human alcohol laboratory study with one oral dose of 2g probenecid or placebo administered in two laboratory sessions.
What is the current status of trial NCT04218357?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2020-12-02. Estimated completion is 2023-05-20.
What interventions are being tested in trial NCT04218357?
The interventions under investigation include: Probenecid or placebo single administration (DRUG).
Who is sponsoring clinical trial NCT04218357?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.